SUNHYDROGEN, INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that SUNHYDROGEN, INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($8.23M) | Sep 15, 2025 |
| FY2025 | Jun 30, 2024 | ($9.88M) | Sep 15, 2025 |
| FY2024 | Jun 30, 2023 | $975.0K | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $90.03M | Sep 29, 2023 |
| FY2022 | Jun 30, 2021 | ($81.50M) | Oct 7, 2022 |
| FY2021 | Jun 30, 2020 | ($57.53M) | Oct 8, 2021 |
| FY2020 | Jun 30, 2019 | $3.98M | Sep 23, 2020 |
| FY2019 | Jun 30, 2018 | ($10.20M) | Sep 30, 2019 |
| FY2018 | Jun 30, 2017 | $2.24M | Sep 25, 2018 |
| FY2017 | Jun 30, 2016 | $6.04M | Sep 21, 2017 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($5.82M) | Sep 15, 2025 |
| FY2025 | Jun 30, 2024 | ($5.00M) | Sep 15, 2025 |
| FY2024 | Jun 30, 2023 | ($9.27M) | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | ($4.48M) | Sep 29, 2023 |
| FY2022 | Jun 30, 2021 | ($5.81M) | Oct 7, 2022 |
| FY2021 | Jun 30, 2020 | ($1.68M) | Oct 8, 2021 |
| FY2020 | Jun 30, 2019 | ($1.83M) | Sep 23, 2020 |
| FY2019 | Jun 30, 2018 | ($750.8K) | Sep 30, 2019 |
| FY2018 | Jun 30, 2017 | ($602.2K) | Sep 25, 2018 |
| FY2017 | Jun 30, 2016 | ($481.3K) | Sep 21, 2017 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $3.44M | Sep 15, 2025 |
| FY2025 | Jun 30, 2024 | $2.57M | Sep 15, 2025 |
| FY2024 | Jun 30, 2023 | $3.44M | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $1.79M | Sep 29, 2023 |
| FY2022 | Jun 30, 2021 | $2.00M | Oct 7, 2022 |
| FY2021 | Jun 30, 2020 | $615.7K | Oct 8, 2021 |
| FY2020 | Jun 30, 2019 | $528.9K | Sep 23, 2020 |
| FY2019 | Jun 30, 2018 | $245.7K | Sep 30, 2019 |
| FY2018 | Jun 30, 2017 | $140.3K | Sep 25, 2018 |
| FY2017 | Jun 30, 2016 | $12.1K | Sep 21, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($3.65M) | Sep 15, 2025 |
| FY2025 | Jun 30, 2024 | ($1.84M) | Sep 15, 2025 |
| FY2024 | Jun 30, 2023 | ($4.26M) | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | ($3.44M) | Sep 29, 2023 |
| FY2022 | Jun 30, 2021 | ($5.38M) | Oct 7, 2022 |
| FY2021 | Jun 30, 2020 | ($695.8K) | Oct 8, 2021 |
| FY2020 | Jun 30, 2019 | ($853.7K) | Sep 23, 2020 |
| FY2019 | Jun 30, 2018 | ($708.8K) | Sep 30, 2019 |
| FY2018 | Jun 30, 2017 | ($573.3K) | Sep 25, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $17.0K | Sep 15, 2025 |
| FY2025 | Jun 30, 2024 | $23.3K | Sep 15, 2025 |
| FY2024 | Jun 30, 2023 | $33.8K | Sep 30, 2024 |
| FY2022 | Jun 30, 2021 | $213.9K | Oct 7, 2022 |
| FY2021 | Jun 30, 2020 | $780 | Oct 8, 2021 |
| FY2020 | Jun 30, 2019 | $13.1K | Sep 23, 2020 |
| FY2019 | Jun 30, 2018 | $1.9K | Sep 30, 2019 |
| FY2015 | Jun 30, 2014 | $2.0K | Sep 28, 2015 |
| FY2013 | Jun 30, 2013 | $4.2K | Oct 31, 2013 |
| FY2012 | Jun 30, 2012 | $4.2K | Sep 28, 2012 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $37.92M | Sep 15, 2025 |
| FY2025 | Jun 30, 2024 | $43.37M | Sep 15, 2025 |
| FY2024 | Jun 30, 2023 | $51.21M | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $52.21M | Sep 29, 2023 |
| FY2022 | Jun 30, 2021 | $56.24M | Oct 7, 2022 |
| FY2021 | Jun 30, 2020 | $291.8K | Oct 8, 2021 |
| FY2020 | Jun 30, 2019 | $150.6K | Sep 23, 2020 |
| FY2019 | Jun 30, 2018 | $196.6K | Sep 30, 2019 |
| FY2018 | Jun 30, 2017 | $165.8K | Sep 25, 2018 |
| FY2017 | Jun 30, 2016 | $160.5K | Sep 21, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $674.9K | Sep 15, 2025 |
| FY2025 | Jun 30, 2024 | $759.5K | Sep 15, 2025 |
| FY2024 | Jun 30, 2023 | $377.0K | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $27.31M | Sep 29, 2023 |
| FY2022 | Jun 30, 2021 | $136.81M | Oct 7, 2022 |
| FY2021 | Jun 30, 2020 | $62.12M | Oct 8, 2021 |
| FY2020 | Jun 30, 2019 | $6.66M | Sep 23, 2020 |
| FY2019 | Jun 30, 2018 | $13.21M | Sep 30, 2019 |
| FY2018 | Jun 30, 2017 | $4.42M | Sep 25, 2018 |
| FY2017 | Jun 30, 2016 | $7.96M | Sep 21, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $36.58M | Sep 15, 2025 |
| FY2025 | Jun 30, 2024 | $41.72M | Sep 15, 2025 |
| FY2025 | Jun 30, 2023 | $49.74M | Sep 15, 2025 |
| FY2024 | Jun 30, 2022 | $24.64M | Sep 30, 2024 |
| FY2023 | Jun 30, 2021 | ($80.57M) | Sep 29, 2023 |
| FY2022 | Jun 30, 2020 | ($61.83M) | Oct 7, 2022 |
| FY2021 | Jun 30, 2019 | ($6.51M) | Oct 8, 2021 |
| FY2020 | Jun 30, 2018 | ($13.02M) | Sep 23, 2020 |
| FY2019 | Jun 30, 2017 | ($4.25M) | Sep 30, 2019 |
| FY2018 | Jun 30, 2016 | ($7.80M) | Sep 25, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($100.08M) | Sep 15, 2025 |
| FY2025 | Jun 30, 2024 | ($91.85M) | Sep 15, 2025 |
| FY2024 | Jun 30, 2023 | ($81.97M) | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | ($82.95M) | Sep 29, 2023 |
| FY2022 | Jun 30, 2021 | ($172.98M) | Oct 7, 2022 |
| FY2021 | Jun 30, 2020 | ($75.55M) | Oct 8, 2021 |
| FY2020 | Jun 30, 2019 | ($18.02M) | Sep 23, 2020 |
| FY2019 | Jun 30, 2018 | ($22.00M) | Sep 30, 2019 |
| FY2018 | Jun 30, 2017 | ($11.80M) | Sep 25, 2018 |
| FY2017 | Jun 30, 2016 | ($14.04M) | Sep 21, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $34.63M | Sep 15, 2025 |
| FY2025 | Jun 30, 2024 | $39.04M | Sep 15, 2025 |
| FY2024 | Jun 30, 2023 | $37.19M | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | $27.68M | Sep 29, 2023 |
| FY2022 | Jun 30, 2021 | $56.01M | Oct 7, 2022 |
| FY2021 | Jun 30, 2020 | $195.0K | Oct 8, 2021 |
| FY2021 | Jun 30, 2019 | $35.1K | Oct 8, 2021 |
| FY2020 | Jun 30, 2018 | $97.3K | Sep 23, 2020 |
| FY2019 | Jun 30, 2017 | $80.1K | Sep 30, 2019 |
| FY2018 | Jun 30, 2016 | $119.9K | Sep 25, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Jun 30, 2022 | $827.5K | Oct 7, 2022 |
| FY2021 | Jun 30, 2021 | $1.27M | Oct 8, 2021 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 0 | Sep 15, 2025 |
| FY2025 | Jun 30, 2024 | 0 | Sep 15, 2025 |
| FY2024 | Jun 30, 2023 | 0 | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | 0 | Sep 29, 2023 |
| FY2022 | Jun 30, 2021 | 0 | Oct 7, 2022 |
| FY2018 | Jun 30, 2018 | 0 | Sep 25, 2018 |
| FY2018 | Jun 30, 2017 | 0 | Sep 25, 2018 |
| FY2017 | Jun 30, 2016 | 0 | Sep 21, 2017 |
| FY2016 | Jun 30, 2015 | 0 | Sep 21, 2016 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 0 | Sep 15, 2025 |
| FY2025 | Jun 30, 2024 | 0 | Sep 15, 2025 |
| FY2023 | Jun 30, 2023 | 0 | Sep 29, 2023 |
| FY2023 | Jun 30, 2022 | 0 | Sep 29, 2023 |
| FY2022 | Jun 30, 2021 | 0 | Oct 7, 2022 |
| FY2018 | Jun 30, 2018 | 0 | Sep 25, 2018 |
| FY2018 | Jun 30, 2017 | 0 | Sep 25, 2018 |
| FY2017 | Jun 30, 2016 | 0 | Sep 21, 2017 |
| FY2016 | Jun 30, 2015 | 0 | Sep 21, 2016 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 5.44B | Sep 15, 2025 |
| FY2025 | Jun 30, 2024 | 5.09B | Sep 15, 2025 |
| FY2024 | Jun 30, 2023 | 4.82B | Sep 30, 2024 |
| FY2023 | Jun 30, 2022 | 4.27B | Sep 29, 2023 |
| FY2022 | Jun 30, 2021 | 3.85B | Oct 7, 2022 |
| FY2021 | Jun 30, 2020 | 2.05B | Oct 8, 2021 |
| FY2020 | Jun 30, 2019 | 1.08B | Sep 23, 2020 |
| FY2019 | Jun 30, 2018 | 852.46M | Sep 30, 2019 |
| FY2018 | Jun 30, 2017 | 699.48M | Sep 25, 2018 |
| FY2017 | Jun 30, 2016 | 589.55M | Sep 21, 2017 |